Private healthcare already participates in half of clinical trials

Specifically, they collaborate in 48.5 percent of them according to Farmaindustria data Source: www.sanidadprivada.publicacionmedica.com Between 2004 and 2018, private health centers have participated in 1,431 clinical trials. Thus, they participate in 48.5 percent of the total developed in Spain, according to the data of the BEST Project of Excellence in Clinical Research of Medicines in […]

Spain takes a step forward in clinical research in early phases in pediatrics and rare diseases

Farmaindustria is working on a new online Guide for Early Phase Clinical Research Units for the benefit of the research community The University Hospital La Paz hosts the IV Conference on Clinical Trials in Phase I in Spain Source: www.farmaindustria.es The clinical research of new drugs in early phases, which involve greater complexity and are […]

CAR-T therapy, future option to improve the treatment of multiple myeloma

The day ‘Controversies in patients with myeloma: candidate or not to haematopoietic transplantation and in relapse’, organized by the Jiménez Díaz Foundation and the San Carlos Clinical Hospital, was discussed. Source: IM Médico Publimas Digital s.l. Multiple myeloma is a disease in continuous evolution and, therefore, of great interest from the scientific and welfare point […]

The resignation of May dilates the concern of the pharmaceutical companies before a Brexit without agreement

After almost three years at the head of the Government, Theresa May has announced that she will present her resignation on June 7. Source: www.consalud.es This 2019 is the year in which the exit of the United Kingdom from the European Union, commonly called Brexit, will be executed, but the negotiations have not reached ‘good […]

Clinical trials, key to developing new drugs and valuable for the economy and cost savings health

Source: www.farmaindustria.es Each new drug that reaches patients has one behind or, in general, several successful clinical trials. The clinical trial, which in the vast majority of cases (eight out of ten in Spain) is driven by the pharmaceutical industry, represents the final stage of this complex, prolonged and risky background race that involves the […]

Savings of 10,000 euros / patient for the clinical trials of the industry

Source: www.redaccionmedica.com The clinical trials promoted by the pharmaceutical industry “are not only vital to develop new treatments for patients, but also play an important role in promoting the economic development of the communities where they are developed,” said John Corea, vice president of Phrma, on the occasion of the World Clinical Trial Day, which […]

Conference “University research and regulatory compliance of the RGPD”

Source: www.farmaindustria.es Scientific research in general, and biomedical research in particular, are activities of general public interest, given the benefits they bring to society as a whole. For this reason, the treatment of personal data for scientific research purposes, both in the public and private spheres, and especially in the context of clinical trials, should […]

An atlas at the individual cell level will improve precision medicine in breast cancer

It reveals the diversity of cancer and immune cells in the tumor ecosystem, with the aim of better selecting treatments. Source: immedicohospitalario.es Investigadores University of Zurich and IBM Research examined by mass spectrometry cellular composition of 144 breast tumors and 50 control samples tissue, establishing in the process the first atlas describing the heterogeneity of […]

The protection of intellectual property, key to the development of new medicines

Source: immedicohospitalario.es The regulatory ecosystem for the protection of intellectual property in Europe works. The set of laws, regulations and incentives developed by the European Union to promote innovation favor, in the field of the pharmaceutical industry, an annual investment of around 35,000 million euros in biomedical R & D activities, generating 700,000 jobs throughout […]

New agenda of the Aemps: management by objectives and supply plan

Source: Redaccionmedica.com The Spanish Agency of Medicines and Health Products has presented its Strategic Plan 2019-2022 that includes a total of 11 measures that aim to face the challenges and strengthen the entity during the next four years. Specifically, the Aemps has defined five strategic objectives to achieve through this plan. The 11 measures developed […]